Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Eurofins Dermscan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Amorolfine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Onychomycosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 15, 2024
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Eurofins Dermscan
Deal Size : Inapplicable
Deal Type : Inapplicable